Clinical Trial Update: Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Fast TILs, a tumor-infiltrating lymphocyte therapy, for malignant pleural effusions arising from epithelial or mesothelial tumors; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Malignant Pleural Effusion

Drugs mentioned

• Fast TILs (tumor-infiltrating lymphocytes)

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: Malignant Pleural Effusion, Malignant Mesothelioma | Phase 1 | Status: RECRUITING